Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of Maximum Standardized Uptake Volume in Predicting Tumor Spread Through Air Spaces in Stage IA Lung Cancers Smaller than 2 cm.

Cancers·2026
Same author

Esophageal Exclusion and Retrosternal Bypass in Management of Post-Pneumonectomy Esophagopleural Fistula: A Case Report.

The American journal of case reports·2026
Same author

Mucoepidermoid carcinoma of the thymus: a case report with emphasis on the differential diagnosis.

Pathologica·2025
Same author

Complications following airway resections: Insights from a large contemporary multi-institutional cohort.

The Journal of thoracic and cardiovascular surgery·2025
Same author

Impact of donor-recipient ethnic matching on survival after lung transplantation in Italy.

Updates in surgery·2025
Same author

Carinal Resection for Cancer.

Seminars in thoracic and cardiovascular surgery·2025
Same journal

Colchicine for Prevention of Perioperative Atrial Fibrillation and Myocardial Injury After Major Thoracic Surgery: Surgical Subgroup Analyses From the COP-AF Trial.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same journal

Corrigendum to: Colchicine prevents perioperative myocardial injury in cardiac surgery by inhibiting the formation of neutrophil extracellular traps: evidence from rat models.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same journal

Mitral valve anomalies in transposition of the great arteries.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same journal

Oncologic Safety of Omitting Mediastinal Lymph Node Dissection in Segmentectomy for Ground-Glass Opacity-Dominant Lung Cancer: A Supplementary Analysis of JCOG1211.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same journal

Progress in Thymic Malignancy Care: The Imperative for Global Standards and Collaboration.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same journal

Association between interventional cardiologist practice characteristics, CABG use, and clinical outcomes.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Thymoma and thymic carcinoma.

Federico Venuta1, Marco Anile, Daniele Diso

  • 1University of Rome Sapienza, Azienda Policlinico Umberto I, Department of Thoracic Surgery, Rome, Italy. federico.venuta@uniroma1.it

European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|July 21, 2009
PubMed
Summary
This summary is machine-generated.

Thymoma and thymic carcinoma are diverse tumors. Multimodality treatment, including induction therapy, improves surgical outcomes and survival for advanced thymic cancers.

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice
17:59

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Published on: April 3, 2011

Related Experiment Videos

Last Updated: Jun 21, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice
17:59

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Published on: April 3, 2011

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Pathology

Background:

  • Thymoma and thymic carcinoma exhibit significant heterogeneity in morphology and clinical behavior.
  • Prognosis depends on staging, WHO histological type, and tumor size.
  • Advanced stage disease presents challenges for complete resection and long-term survival.

Purpose of the Study:

  • To review current understanding and management strategies for thymoma and thymic carcinoma.
  • To highlight the role of multimodality treatment in improving outcomes.
  • To discuss emerging therapeutic approaches and future directions.

Main Methods:

  • Review of existing literature on thymoma and thymic carcinoma management.
  • Analysis of prognostic variables including staging and histology.
  • Evaluation of multimodality treatment protocols, including induction therapy.

Main Results:

  • Complete surgical resection remains the gold standard for curative treatment.
  • Multimodality approaches, integrating surgery, chemotherapy, and radiotherapy, improve outcomes.
  • Induction therapy enhances resectability and survival in inoperable cases, reducing recurrence rates.

Conclusions:

  • Integrated treatment strategies, based on accurate histology and staging, are crucial for optimizing patient prognosis.
  • Multidisciplinary collaboration is essential for standardized and effective management.
  • Further research and prospective studies are needed to validate novel therapies.